Underrepresented Populations
The problem of underrepresentation becomes even more striking in light of recent advances in the understanding of how your family history and your genetic makeup can influence your response to treatment. Researchers now recognize that people respond differently to medications based in part on their genetic makeup.12
Clinical trial roadblocks may include:
- Transportation issues to and from the treating trial center
- Additional costs associated with daily living expenses while undergoing treatment
- Lack of childcare while participating in the clinical trial
- Regional and/or family customs
- Language barriers are contributing factors to lower enrollment. Language lines are available for non-English speaking individuals should they wish to seek additional information on participation.
- Lengthy and complex consent forms
- Vague information about insurance coverage of clinical trials
- Doubts about safety of the trial also play a role in decreased enrollment
- Employment issues such as decreased pay or lack of paid time off
With increased awareness and education targeted at underrepresented populations the ultimate goal will be to ensure a more equal enrollment of that group in clinical trials.
12[1]AARP Bulletin Today, Seniors, Women and Minorities Underrepresented in Clinical Trials, Experts Say. Retrieved 2/28/2009 from
http://bulletin.aaqwrg/yourhealth/policy/articles/clinical trials why.html
Back to the Table of Contents
Next: Patient Resources


